Background illustration for clinical trials search

Paid Clinical Trials Renton

Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Seattle WA, Los Angeles CA, Duarte CA, Denver CO,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

for
Influenza
Location: Seattle WA, Chicago IL
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 70+

Code: NCT05832307

Recruiting

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Seattle WA, San Francisco CA, Aurora CO, Phoenix AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0 - 6

Code: NCT07112378

Phase3, Recruiting

Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis

for
Eosinophilic Esophagitis (EoE)
Location: Seattle WA
Sponsor: Kate Farms Inc

Sex: All

Age: 1 - 21

Code: NCT07234825

Recruiting

Childhood Cancer Survivor Study

for
Cancer
Location: Seattle WA, San Francisco CA, Stanford CA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Puyallup WA, Lacey WA, Portland OR, Corvallis OR,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

for
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG,
Location: Seattle WA, Aurora CO, Houston TX, Ann Arbor MI,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT06838676

Phase2, Recruiting

REACT-01: Reversing Autoimmunity Through Cell Therapy

for
Systemic Lupus Erythematosus
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 2 - 30

Code: NCT06465147

Phase1, Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Olympia WA, Portland OR, Spokane WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Seattle WA, Portland OR, Spokane WA, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Olympia WA, Portland OR, Edmonton, Reno NV, Billings MT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

for
Chronic Myelogenous Leukemia,
Location: Seattle WA, Edmonton, Cincinnati OH, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 18

Code: NCT07354074

Phase2, Recruiting

Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials

for
Duchenne Muscular Dystrophy (DMD), Cardiomyopathy,
Location: Seattle WA, Sacramento CA, Chicago IL, Indianapolis IN,
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 0+

Code: NCT07674758

Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Seattle WA, Chicago IL, Houston TX, Ann Arbor MI,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT05843253

Phase2, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Seattle WA, Palo Alto CA, Orange CA, Denver CO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Tacoma WA, Edmonton, Salt Lake City UT, Rapid City SD,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Seattle WA, Missoula MT, Edmonton, Santa Rosa CA,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Seattle WA, Portland OR, Rochester MN, Milwaukee WI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06158854

Phase1, Phase2, Recruiting

Effectiveness of Aurix Therapy in Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Bremerton WA, Meridian ID, Visalia CA, Arcadia CA,
Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352454

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Seattle WA, Tacoma WA, Portland OR, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting